Injuries: Diabetes drugs have failed to warn users of the increased risk of developing Gangrene. Symptoms of Fournier's Gangrene include:
Were you or a loved one diagnosed with Fournier’s gangrene after taking Invokana or another SGLT2 inhibitor. You may be eligible to file a product liability lawsuit.
Not sure how to get started? We can help. Contact our compassionate legal team for a free consultation.
Invokana has been linked to a severe, in some cases fatal, genital infection. On Wednesday, August 29, 2018, the US Food & Drug Administration warned patients and health care providers that a class of type 2 diabetes medications can cause Fournier’s gangrene, a form of necrotizing fasciitis, or flesh-eating bacteria, that attacks the genitals.
Did you or a loved one develop genital gangrene, or necrotizing fasciitis of the perineum, after taking Invokana, Farxiga, Jardiance or another SGLT2 inhibitor indicated for the treatment of type 2 diabetes? You may be entitled to substantial financial compensation.
Some patients may be eligible to pursue justice by filing a product liability lawsuit. Our experienced attorneys can help. We understand how sensitive this condition, genital gangrene or Fournier’s gangrene, can be. Contact our lawyers today for a free, confidential consultation. Our compassionate legal team can help you understand your rights and options – at no charge and no obligation. You have nothing to lose – and everything to gain – from reaching out. Let us help you on the road to recovery.
SGLT2 inhibitors help to treat type 2 diabetes by promoting the flushing of sugars in the urine. But as Bruce Y. Lee of Forbes explains in a recent report, increased sugar in the urine creates a perfect breeding ground for bacteria. For this reason, pharmaceutical manufacturers have long warned that SGLT2 inhibitors, which increase the level of sugar in the genitals, can lead to an increased risk for urinary tract and yeast infections.
“In rare situations,” Lee writes, “bacteria such as Clostridium perfringens, Group A Streptococcus, Staphylococcus aureus, and Vibrio vulnificus can cause Fournier’s gangrene when they invade” and start consuming the genital flesh.
Genital gangrene is a true medical emergency. In severe cases, the infection can spread throughout the body and become fatal. While most cases of genital gangrene are seen in men between the ages of 50 and 79, the FDA has identified cases linked to Invokana or another SGLT2 inhibitor in both men and women.
Reviewing data from the last five years, FDA researchers identified 12 cases of the life-threatening disease in SGLT2 patients. “Fournier’s gangrene,” the FDA says, “developed within several months of the patients starting an SGLT2 inhibitor and the drug was stopped in most cases.” All 12 patients were hospitalized for their injuries and underwent surgery. At least one patient died, while several others required multiple “disfiguring” procedures.
As a point of comparison, other antidiabetic drugs have only been linked to 6 cases of Fournier’s gangrene over the last 30 years. In response to this increased risk, the FDA is requiring SGLT2 inhibitor manufacturers to include a new warning in their product labeling.
SGLT-2 inhibitors include such bestselling medications as Invokana, Invokamet, Farxiga and Jardiance.
Were you or a loved one affected by this terrible? Had you previously been prescribed Invokana, Farxiga or another SGLT2 inhibitor? Contact our dedicated legal team now for a free, no obligation consultation. We are here for you. If you suffered severe injuries, you owe it to yourself to explore your legal options. Let us help in your fight for justice.
Continue Reading: Hip Replacement Lawsuits: Injured Patients Pursue Compensation
National Organization for Rare Diseases: Fournier Gangrene
WebMD: What is Fournier's Gangrene?